Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02601313 |
|---|---|
| Brief Title: | Study of Brexucabtagene Autoleucel (KTE-X19) in Participants With Relapsed/Refractory Mantle Cell Lymphoma (Cohort 1 and Cohort 2) (ZUMA-2) |
| First Submitted : | November 6, 2015 |
| First Submitted that Met QC Criteria : | November 6, 2015 |
| First Posted : | November 10, 2015 (Estimate) |
| Results First Submitted : | August 21, 2020 |
| Results First Submitted that Met QC Criteria : | August 21, 2020 |
| Results First Posted : | September 10, 2020 |
| Certification/Extension First Submitted : | July 17, 2020 |
| Certification/Extension First Submitted that Met QC Criteria : | July 17, 2020 |
| Certification/Extension First Posted : | July 21, 2020 |
| Last Update Submitted that Met QC Criteria : | February 8, 2024 |
| Last Update Posted : | February 12, 2024 |